Malaria

Doctor Salim Abdulla

Chief Executive Director, Ifakara Health Institute, Dar es Salaam, United Republic of Tanzania

Dr. Salim Abdulla is a clinical epidemiologist with over 15 years’ experience in the conduct of Phase I to Phase IV clinical trials, mainly focused on malaria. He has worked on the large-scale evaluation of insecticide-treated bednets, antimalarial drug resistance, and artemisinin-based combination therapy. Dr Abdulla also has experience in the development and implementation of malaria surveillance systems and conduct of national surveys for malaria indicators and drug resistance. He currently leads one of the groups involved in the evaluation of new malaria vaccines and treatments for regulatory licensure.

Dr. Salim Abdulla is a clinical epidemiologist with over 15 years’ experience in the conduct of Phase I to Phase IV clinical trials, mainly focused on malaria. He has worked on the large-scale evaluation of insecticide-treated bednets, antimalarial drug resistance, and artemisinin-based combination therapy. Dr Abdulla also has experience in the development and implementation of malaria surveillance systems and conduct of national surveys for malaria indicators and drug resistance. He currently leads one of the groups involved in the evaluation of new malaria vaccines and treatments for regulatory licensure.

Dr Abdulla has published extensively and serves on various national and international technical committees. He maintains a keen interest in translating research into policy and practice and played an important role in the formulation of national policy on ITNs and malaria treatment. He is presently involved in the development of a policy decision-making framework for malaria vaccines.

Last updated: 15 December 2011

Share